The National Cancer Institute (NCI) is ending its support for a 26-year-old push to advance clinical trials for children with ...

The risk of developing a malignant brain tumor is significantly higher in patients with a history of moderate-to-severe — but not mild — traumatic brain injury, new data show.

Moderate-to-severe traumatic brain injury (TBI) was tied to an increased risk of subsequent brain cancer, a retrospective ...

The FDA has approved a new drug called Modeyso for the treatment of diffuse midline glioma (DMG), a rare and aggressive brain ...

The National Cancer Institute is phasing out the Pediatric Brain Tumor Consortium, a prominent clinical trial network that ...

A study looking at the biophysical properties of an abnormal protein driving cancer cells is giving scientists new ...

A network of hospitals and cancer centers dedicated to early phase trials of novel treatments will no longer receive federal funding.

Clare Smerdon, 37, was diagnosed with a grade 4 astrocytoma — just weeks after her son Teddy turned 13 months.

New research led by investigators at Mass General Brigham suggests a link between a history of traumatic brain injury (TBI) ...

Days before her surgery, McCall admitted that she had to consider the worst — something she never had to think about before.